Standardized shatavari root extract demonstrates ovarian, hormonal, and metabolic benefits in women with PCOS

The standardized extract Xeya Modern Shatavari from NXT USA demonstrates multiple health benefits for women with the endocrine disorder polycystic ovary syndrome (PCOS), a new clinical study shows.¹ PCOS is a major cause of female infertility, the study notes, and affects approximately 5–15% of women worldwide. The disorder is also associated with other conditions including insulin resistance, cardiovascular risks, and depression.

The botanical extract is derived from Asparagus racemosus (shatavari) roots and is used in traditional Ayurvedic medicine for reproductive health benefits. This extract has also been tested in 2025 in a clinical trial for its effect on menopause symptom management, finding significantly reduced symptoms and an increase in quality of life.² 

Study design

The study, “CL22209, a standardized Asparagus racemosus root extract, demonstrates improved ovarian morphology, menstrual regularity, and metabolic parameters in women with polycystic ovary syndrome in a randomized, controlled trial,” was published in Food & Nutrition Research in December 2025. Xeya Modern Shatavari was referred to as CL22209 in the study.

This 84-day randomized, double-blind, placebo-controlled clinical trial involved 60 women aged 20 to 35 years with PCOS. The participants received either once capsule of 100 mg daily of the extract (standardized to 15% shatavarins) or a placebo, and were not given instructions to change their daily diet or lifestyle. They also participated in four scheduled visits in the study, including follow-ups.

The primary outcome of this study was the change in ovarian volume from baseline measurements, with secondary measurements being exploratory and including hormonal, metabolic, and anthropometric measures. Safety of the supplement was also evaluated.

Study results: ovarian, hormonal, and metabolic changes

At the end of the study, participants in the supplement group demonstrated significant improvements compared to placebo.

Highlighted results in the supplement group include:

• Mean ovarian volume was reduced by 20.98% compared with placebo
• Cyst size was reduced by 40.97%
• Follicle number was reduced by 20.56%
• Hormone normalization was observed through an increase in sex hormone-binding globulin levels (SHBG) and reduced serum testosterone (TT) levels
• The luteinizing hormone and follicle stimulating hormone ratio (LH:FSH) decreased
• Insulin sensitivity significantly improved

The reductions in TT contributed to reductions in hirsutism (excessive hair growth) and acne. Menstrual patterns and anthropometric changes (body weight, waist and hip circumferences) saw moderate changes.

Ultimately, the proof-of-concept study determined the supplement to be an effective management strategy for PCOS, targeting both endocrine and metabolic factors. “CL22209 was well-tolerated and demonstrated broad-spectrum efficacy in women diagnosed with PCOS, improving ovarian morphology, metabolic health, and androgen-mediated symptoms,” they concluded. “Future studies with larger sample sizes and longer follow-up durations would help to further validate these findings and clarify CL22209’s role in the management of PCOS.”

Natural supplements for hormone balance

Most available pharmacotherapies target specific symptoms rather than the condition itself, the study notes, also stating that the supplement offered a promising plant-based therapy for holistic management of the condition.

“Many women don’t realize how deeply hormonal imbalance can influence reproductive health, metabolism, and skin,” stated Eric Anderson, managing director of NXT USA, in a January 13, 2026, press release.³ “Xeya Modern Shatavari supports natural hormone balance, helping promote healthy ovarian function, consistent cycles, and hormonal markers tied to clear skin and metabolic resilience.”

The press release also noted that the extract is wildcrafted from regulated management of forests, dried by local women’s cooperative, and processed using purified water and organic ethanol.

References

1. Kondamudi, S.; Sadu, S.; Deva, S.; Yalamanchi, A.; Yalamanchi, A. CL22209, a standardized Asparagus racemosus root extract, demonstrates improved ovarian morphology, menstrual regularity, and metabolic parameters in women with polycystic ovary syndrome in a randomized, controlled trial. Food & Nutrition Research. 2025. 69: 13244. DOI: 10.29219/fnr.v69.13244.
2. McEvoy, E. Clinical study finds shatavari extract reduces hot flashes and night sweats in perimenopausal women. September 8, 2025. https://www.nutritionaloutlook.com/view/clinical-study-finds-shatavari-extract-reduces-hot-flashes-and-night-sweats-in-perimenopausal-women (Accessed 2026-01-13).
3. NXT USA. Xeya Modern Shatavari™ New Published Study Highlights Comprehensive Support for Ovarian Function, Metabolic Health, and Hormone Balance—Areas Critical to Millions of Women. January 13, 2026.